Research shows that compared with normal tissues, GPX4's expression level in tumor tissues is significantly higher, such as colon adenocarcinoma, renal chromophobe cell, renal clear cell carcinoma, lung adenocarcinoma, prostate cancer, rectal adenocarcinoma, thyroid cancer and endometrial cancer. The gene discussed is GPX4; the disease is thyroid gland carcinoma.